Invivo Therapeutics Holdings Quick Ratio (NVIV) starting from the third quarter 2023 to third quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Invivo Therapeutics Holdings Corp   (NASDAQ: NVIV)

Invivo Therapeutics Holdings 's Quick Ratio

NVIV's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Invivo Therapeutics Holdings 's Cash & cash equivalent, this led to improvement in Invivo Therapeutics Holdings 's Quick Ratio to 12.88, above Invivo Therapeutics Holdings Corp average Quick Ratio.

Within Medical Equipment & Supplies industry 9 other companies have achieved higher Quick Ratio than Invivo Therapeutics Holdings in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 242 to 264.

Explain Quick Ratio?
How much Cash & cash equivalents NVIV´s has?
What are NVIV´s Current Liabilities?




NVIV Quick Ratio (Sep 30 2023)
Q3
(Jun 30 2023)
Q2
(Mar 31 2023)
Q1
(Dec 31 2022)
Q4
(Sep 30 2022)
Q3
Y / Y Current Liabilities Change -68.5 % -55.94 % -28.82 % -7.95 % 30.01 %
Y / Y Cash & cash equivalent Change -19.02 % -17.72 % -13.36 % -14.08 % -49.78 %
Quick Ratio MRQ 12.88 11.99 10.82 7.89 5.01
NVIV's Total Ranking # 264 # 242 # 231 # 159 # 800
Seq. Current Liabilities Change -25.5 % -26.42 % -41.36 % -1.99 % 4.19 %
Seq. Cash & cash equivalent Change -19.95 % -18.47 % -19.58 % 54.3 % -18.66 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 10
Healthcare Sector # 130
Overall Market # 264


Quick Ratio Statistics
High Average Low
21.77 6.27 0.13
(Mar 31 2021)   (Dec 31 2011)




Financial Statements
Invivo Therapeutics Holdings 's Current Liabilities $ 1 Millions Visit NVIV's Balance sheet
Invivo Therapeutics Holdings 's Cash & cash equivalent $ 9 Millions Visit NVIV's Balance sheet
Source of NVIV's Sales Visit NVIV's Sales by Geography


Cumulative Invivo Therapeutics Holdings 's Quick Ratio

NVIV's Quick Ratio for the trailling 12 Months

NVIV Quick Ratio

(Sep 30 2023)
12 Months
(Jun 30 2023)
12 Months
(Mar 31 2023)
12 Months
(Dec 31 2022)
12 Months
(Sep 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth -40.17 % -17.31 % 6.04 % 23.03 % 38.88 %
Y / Y Cash & cash equivalent TTM Growth -15.62 % -25.64 % -32.18 % -37.3 % -46.41 %
Quick Ratio TTM 10.07 8.07 7.15 6.96 7.14
Total Ranking TTM # 149 # 245 # 320 # 431 # 442
Seq. Current Liabilities TTM Growth -23 % -15.28 % -6.21 % -2.21 % 6.41 %
Seq. Cash & cash equivalent TTM Growth -3.97 % -4.34 % -3.68 % -4.63 % -15.37 %


On the trailing twelve months basis Current Liabilities decreased faster than Invivo Therapeutics Holdings 's average Cash & cash equivalent, this led to increase in in Invivo Therapeutics Holdings 's Quick Ratio to 10.07, above NVIV average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 213 other companies have achieved higher Quick Ratio than Invivo Therapeutics Holdings . While Quick Ratio overall ranking has improved so far to 3391, from total ranking during the twelve months ending second quarter 2023 at 3431.

Explain Quick Ratio?
How much Cash & cash equivalents NVIV´s has?
What are NVIV´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 214
Healthcare Sector # 1003
Within the Market # 264


trailing twelve months Quick Ratio Statistics
High Average Low
14.88 4.86 0.49
(Sep 30 2021)   (Jun 30 2012)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Medical Equipment & Supplies Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Medinotec Inc   22.91 $ 2.839  Millions$ 0.124  Millions
Utah Medical Products Inc  21.12 $ 88.209  Millions$ 4.177  Millions
Pulse Biosciences Inc   20.75 $ 50.386  Millions$ 2.428  Millions
Talkspace Inc   19.25 $ 125.332  Millions$ 6.512  Millions
Heartbeam Inc   18.83 $ 19.184  Millions$ 1.019  Millions
Innovative Eyewear Inc   17.05 $ 3.904  Millions$ 0.229  Millions
Vicarious Surgical Inc  16.21 $ 110.189  Millions$ 6.796  Millions
Vivos Inc  14.31 $ 1.537  Millions$ 0.107  Millions
Alpha Tau Medical Ltd  14.06 $ 84.940  Millions$ 6.040  Millions
Neurometrix Inc   13.99 $ 17.638  Millions$ 1.260  Millions
Inmode Ltd   13.94 $ 741.605  Millions$ 53.213  Millions
Sonendo Inc   13.46 $ 55.939  Millions$ 4.155  Millions
Invivo Therapeutics Holdings Corp   12.88 $ 8.581  Millions$ 0.666  Millions
Co diagnostics Inc   12.44 $ 63.429  Millions$ 5.098  Millions
Shockwave Medical Inc   11.73 $ 917.333  Millions$ 78.203  Millions
Microbot Medical Inc   11.69 $ 15.017  Millions$ 1.285  Millions
Novocure Limited  11.56 $ 921.248  Millions$ 79.668  Millions
Inspire Medical Systems inc   11.37 $ 464.214  Millions$ 40.836  Millions
Cvrx inc   11.20 $ 82.993  Millions$ 7.407  Millions
Hyperfine Inc   10.40 $ 85.424  Millions$ 8.211  Millions
Collplant Biotechnologies Ltd  10.25 $ 26.915  Millions$ 2.627  Millions
Sight Sciences Inc   10.08 $ 144.501  Millions$ 14.331  Millions
Axonics Inc   9.68 $ 344.716  Millions$ 35.593  Millions
Strata Critical Medical Inc   9.31 $ 174.688  Millions$ 18.768  Millions
Inspiremd Inc   9.17 $ 42.998  Millions$ 4.690  Millions
Alpha Pro Tech Ltd   9.16 $ 18.163  Millions$ 1.982  Millions
Nevro Corp   8.92 $ 320.258  Millions$ 35.918  Millions
Transmedics Group Inc   8.70 $ 427.110  Millions$ 49.101  Millions
Modular Medical Inc  8.31 $ 6.330  Millions$ 0.762  Millions
Silk Road Medical Inc   8.03 $ 192.861  Millions$ 24.022  Millions

Date modified: 2026-09-08T15:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.